| Identification | Back Directory | [Name]
1H,5H-Imidazo[1,2-a]pyrrolo[1,2-d]pyrazin-5-one, 2,3,10,10a-tetrahydro-1-[(3-methyl-4-isoxazolyl)carbonyl]-10a-(6-methyl-3-pyridinyl)-, (10aS)- | [CAS]
1323077-88-8 | [Synonyms]
(S)-Enzaplatovir
1H,5H-Imidazo[1,2-a]pyrrolo[1,2-d]pyrazin-5-one, 2,3,10,10a-tetrahydro-1-[(3-methyl-4-isoxazolyl)carbonyl]-10a-(6-methyl-3-pyridinyl)-, (10aS)- | [Molecular Formula]
C20H19N5O3 | [MDL Number]
MFCD34578577 | [MOL File]
1323077-88-8.mol | [Molecular Weight]
377.4 |
| Chemical Properties | Back Directory | [Boiling point ]
663.0±55.0 °C(Predicted) | [density ]
1.46±0.1 g/cm3(Predicted) | [storage temp. ]
Store at -20°C | [solubility ]
DMSO : 200 mg/mL (529.94 mM; Need ultrasonic) | [form ]
Solid | [pka]
6.08±0.12(Predicted) | [color ]
Off-white to yellow |
| Hazard Information | Back Directory | [Biological Activity]
(S)-Enzaplatovir ((S)-BTA-C585) is the S-enantiomer of Enzaplatovir. (S)-Enzaplatovir shows antiviral activities with an EC50 of 56 nM for respiratory syncytial viral (RSV) (patent WO2011094823A1 compound 77)[1]. | [References]
[1]. Jeffrey Peter Mitchell, et al. Compounds for treating respiratory syncytial virus infections. WO2011094823A1 |
|
|